DOD Biotech PCL (BKK:DOD-R) Total Liabilities : ฿173.1 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is DOD Biotech PCL Total Liabilities?

DOD Biotech PCL's Total Liabilities for the quarter that ended in Mar. 2025 was ฿173.1 Mil.

DOD Biotech PCL's quarterly Total Liabilities increased from Sep. 2024 (฿335.82 Mil) to Dec. 2024 (฿394.40 Mil) but then declined from Dec. 2024 (฿394.40 Mil) to Mar. 2025 (฿173.08 Mil).

DOD Biotech PCL's annual Total Liabilities declined from Dec. 2022 (฿397.29 Mil) to Dec. 2023 (฿377.58 Mil) but then increased from Dec. 2023 (฿377.58 Mil) to Dec. 2024 (฿394.40 Mil).

DOD Biotech PCL Total Liabilities Historical Data

The historical data trend for DOD Biotech PCL's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DOD Biotech PCL Total Liabilities Chart

DOD Biotech PCL Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

532.66

364.70

397.29

377.58

394.40

DOD Biotech PCL Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															342.75	328.82	335.82	394.40	173.08

DOD Biotech PCL Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

DOD Biotech PCL's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	365.975	+	(0.286	+	6.6
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	10.945	+	10.593	+	0)
	=	394.4

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	1286.313	-	891.914
	=	394.4

DOD Biotech PCL's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	144.596	+	(0.111	+	6.444
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	10.517	+	11.409	+	0)
	=	173.1

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	1095.202	-	922.125
	=	173.1

DOD Biotech PCL Total Liabilities Related Terms

Thank you for viewing the detailed overview of DOD Biotech PCL's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

DOD Biotech PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » DOD Biotech PCL (BKK:DOD-R) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

DOD:Thailand

Address

No. 111, Moo 2, Tumbol Taa jeen, Amphor Muengsamutsakhon, Samut Sakhon, THA, 74000

Website

https://www.dodbiotech.com

DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The company is organized into business units based on its products and services and has reportable segments as; Supplementary business, Manufacturing cosmetic business, Manufacturing extraction business, and others. A majority of its revenue is generated from the Supplementary business which manufactures and sells dietary supplements in the form of capsules, tablets, soft gels, gummies, probiotics, shot drinks, and others. Geographically, the company operates only in Thailand.

DOD Biotech PCL Headlines

No Headlines